The event series “How does innovation find its way into medicine?” is aimed at everyone who is interested in innovation, looking to establish a company, as well as at start-ups from the healthcare industry.
Young founders, interested in establishing a company in the healthcare industry, who want to convert their ideas into products in small start-ups face challenges, particularly in the medical sector. Medical products, including medical apps, have to undergo thorough checks, and even the registration of simple technical products often requires clinical trials. It is a long and expensive road before the costs of a new product are reimbursed by health insurers. In order to increase the chances of success for start-ups, various obstacles related to medical product development must be put into the focus of daily work at an early stage.
The Tübingen Foundation for Medical Innovations has therefore launched the six-part event series “How does innovation find its way into medicine?”, which addresses the challenges for idea creation in the healthcare sector and aims to discuss improving the chances for those interested in starting a business. In the end, the most important rules for successful market access should be worked out.
After a very successful first event in December 2020 (here a short video summary) with more than 200 participants, the second lecture evening will take place on 04.02.2021 at 16:00-19:00 (CET).
The challenges for startups will be discussed in three short keynote speeches by Prof. Dr. med. Thomas Gottwald (start-up founder & Board Member Ovesco Endoscopy AG), Prof. Dr. Ing. Thomas Bauernhansl (Institute Director Fraunhofer IPA as well as IFF of the University of Stuttgart) and Günther Steffen (Fund Manager at Zukunftsfonds Heilbronn as well as Supervisor of Biotech and Medtech companies).
This will be followed by a roundtable debate with Winfried Plötze (Managing Director Baden-Württemberg, BARMER), Prof. Stefan Laufer (Start-up Founder, Head of Chair Pharm./Med. Chemistry, Tübingen Center for Academic Drug Discovery, Department of Pharmacy & Biochemistry, EKUT), Dr. Timo Schmelzpfenning (authorized Signatory and Head of Research & Development, SPORLASTIC GmbH), Prof. Dr. Ralf Kindervater (Managing Director, BIOPRO Baden-Württemberg GmbH), and Prof. Dr. med. Eberhart Zrenner (Nonprofit Foundation for Medical Innovations).
Finally, individual mentoring sessions with industry experts will be offered for specific questions (regarding market access in the healthcare industry, registration of medical products, clinical trials, and intellectual property rights) in separate online sessions.
For the registration link, agenda und the additional registration for the mentoring sessions (until 2 February 2021) please click here.